Cargando…
MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α
Breast cancer is the most commonly diagnosed malignant tumor among females. Estrogen receptor α (ERα) is initially expressed in 70% of breast cancers and is a well-known target of endocrine therapy for ERα-positive breast cancer. In the present study, we identified MINDY1, a member belongs to the mo...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514509/ https://www.ncbi.nlm.nih.gov/pubmed/34645792 http://dx.doi.org/10.1038/s41419-021-04244-z |